Indoco Remedies Ltd.

INDOCO

Market Cap
₹3,185 Cr.
P/E
32.35

Indoco Remedies Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
13.83%
3yr Average
14.35%
5yr Average
9.23%
Net Profit Margin
Latest
8.53%
3yr Average
8.69%
5yr Average
5.59%
ROCE
Latest
16.9%
3yr Average
19.05%
5yr Average
13.14%
Debt to Equity
Latest
0.31
3yr Average
0.3
5yr Average
0.35
Market Share
0.24% (as of Jul 22)
Anti - Diabetes - Market Share
0.99% (as of Jul 22)
Anti-Infectives - Market Share
0.60% (as of Nov 21)
Blood Related - Market Share
0.02% (as of Jul 22)
Cardiovascular - Market Share
5.50% (as of Mar 23)
Carmicide - Market Share
locked Source
49.90% (as of Mar 23)
Cyclopam - Market Share
locked Source
0.36% (as of Nov 21)
Dermatology - Market Share
0.82% (as of Jul 22)
Gastro-Intestinal - Market Share
0.24% (as of Nov 21)
Gynecology - Market Share
88.70% (as of Mar 23)
Homide - Market Share
locked Source
65.60% (as of Mar 23)
Karvol Plus - Market Share
locked Source
63.20% (as of Mar 23)
Kidodent - Market Share
locked Source
2.12% (as of Nov 21)
Ophthalmology - Market Share
0.30% (as of Nov 21)
Pain - Market Share
0.60% (as of Dec 22)
Pharmaceutical Sector - Market Share
52.20% (as of Mar 23)
Renolen - Market Share
locked Source
1.50% (as of Nov 21)
Respiratory - Market Share
80% (as of Mar 23)
Rexidin M - Market Share
locked Source
55.50% (as of Mar 21)
Rexidin Plus - Market Share
locked Source
97.70% (as of Mar 23)
Sensodent-K - Market Share
locked Source
47.80% (as of Mar 23)
Sensodent-KF - Market Share
locked Source
60.30% (as of Mar 23)
Sensoform - Market Share
locked Source
100% (as of Mar 23)
Snowdent - Market Share
locked Source
23.05% (as of Nov 21)
Stomatological - Market Share
2.45% (as of Nov 21)
Urology - Market Share
0.58% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Formulation

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Global DMFs filed (.)
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Indoco Remedies Ltd.
    One Hidden Stock in the Pharma Sector! Growing Really Fast - SOIC
    Why Indoco Remedies looks Interesting and why FY22-24 growth is likely to be stellar here? - SOIC
    View the discussion on ValuePickr
    Business Analysis - A thread on Indoco Remedies - Value Educator
    Detailed Analysis on the business of Indoco Remedies - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline Timeline